Project List
List projects.
Fields
id (integer)
Primary key.
Expansions
To activate relation expansion add the desired fields as a comma separated
list to the expand query parameter like this:
?expand=<field>,<field>,<field>,...
The following relational fields can be expanded:
organizationcategorytypepartner_functionmanagercontactstatusgrantresearcheventstudylanguageprogramfunders
Filters
To filter for exact value matches:
?<fieldname>=<value>
Possible exact filters:
organizationcategorymanagercontactstatusgrantresearchstudylanguagefundersprogram
For advanced filtering use lookups:
?<fieldname>__<lookup>=<value>
All fields with advanced lookups can also be used for exact value matches as described above.
Possible advanced lookups:
begin_planned:gt,gte,lt,ltebegin_effective:gt,gte,lt,lteend_planned:gt,gte,lt,lteend_effective:gt,gte,lt,lte
GET /v1/research/project/?format=api&offset=660&ordering=-begin_planned
{ "count": 2245, "next": "https://api-test.medunigraz.at/v1/research/project/?format=api&limit=20&offset=680&ordering=-begin_planned", "previous": "https://api-test.medunigraz.at/v1/research/project/?format=api&limit=20&offset=640&ordering=-begin_planned", "results": [ { "id": 6835, "title": { "de": "Erforschung des Einflusses der JAK2V617F Gendosis auf den Phänotyp Myeloproliferativer Erkrankungen mittels CRISPR/Cas9 Genome Engineering.", "en": "Investigating the effect of JAK2V617F gene dosage on MPN phenotype by\r\nforward and reverse CRISPR/Cas9 genome engineering." }, "short": "JAK2 gene dosage", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-01-01T01:00:00+01:00", "end_planned": "2024-12-31T01:00:00+01:00", "end_effective": "2024-12-31T01:00:00+01:00", "assignment": "2021-12-15T10:41:29+01:00", "program": null, "subprogram": null, "organization": 14082, "category": 10, "type": 10, "partner_function": 4, "manager": 50747, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 1375 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "6835-50747-10", "6835-98091-12", "6835-97755-12", "6835-108881-12", "6835-119131-12" ] }, { "id": 6820, "title": { "de": "enFaced 2.0 - AR-Tool für die Gesichtschirurgie", "en": "enFaced 2.0 - Instant AR Tool for Maxillofacial Surgery" }, "short": "enFaced 2.0", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-04-01T02:00:00+02:00", "end_planned": "2024-12-31T01:00:00+01:00", "end_effective": "2026-03-31T02:00:00+02:00", "assignment": "2021-12-09T10:55:12+01:00", "program": 108, "subprogram": null, "organization": 14112, "category": 10, "type": 10, "partner_function": 2, "manager": 76910, "contact": null, "status": 2, "research": 4, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "KLI1044", "ethics_committee": null, "edudract_number": null, "persons": [ "6820-76910-10" ] }, { "id": 6927, "title": { "de": "Charakterisierung der therapierelevanten epigenetischen Grundlagen des fortgeschrittenen Lungenkarzinom ", "en": "Characterizing the epigenetics of lung cancer progression to inform\r\npersonalized treatment" }, "short": "epiLUAD", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-02-01T01:00:00+01:00", "end_planned": "2023-12-31T01:00:00+01:00", "end_effective": "2026-12-31T01:00:00+01:00", "assignment": "2022-02-15T12:48:51+01:00", "program": null, "subprogram": null, "organization": 14085, "category": 10, "type": 10, "partner_function": 4, "manager": 109087, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 1743 ], "funder_projectcode": "MEFO-77", "ethics_committee": null, "edudract_number": null, "persons": [ "6927-109087-10" ] }, { "id": 6760, "title": { "de": "Apolipoprotein AI(apo-AI) Peptid-Lipid Komplexe", "en": "Apolipoprotein AI(apo-AI) Mimetic Peptide Lipid Assemblies" }, "short": "AAMLA", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-01-01T01:00:00+01:00", "end_planned": "2025-12-31T01:00:00+01:00", "end_effective": "2026-11-30T01:00:00+01:00", "assignment": "2021-10-22T11:40:29+02:00", "program": 111, "subprogram": null, "organization": 14011, "category": 10, "type": 10, "partner_function": 3, "manager": 83104, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "I5703", "ethics_committee": null, "edudract_number": null, "persons": [ "6760-83104-10", "6760-83104-12", "6760-107231-12" ] }, { "id": 7025, "title": { "de": "Die Rolle von Neutrophiler Elastase im Lungenkarzinom", "en": "Nuclear function of secreted neutrophil elastase in lung cancer metastasis" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-06-15T02:00:00+02:00", "end_planned": "2026-12-31T01:00:00+01:00", "end_effective": "2026-06-14T02:00:00+02:00", "assignment": "2022-05-18T12:06:31+02:00", "program": 121, "subprogram": null, "organization": 14022, "category": 10, "type": 10, "partner_function": 1, "manager": 60706, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "P35294", "ethics_committee": null, "edudract_number": null, "persons": [ "7025-51163-12", "7025-60706-10", "7025-99558-12", "7025-100698-12", "7025-112858-12", "7025-115261-12" ] }, { "id": 7333, "title": { "de": "Serologisches Antikörper Screening zu SARS-CoV-2, Legionellen und Hepatitis unter Zahnmediziner*innen 2022\r\n", "en": "Serological antibody screening for SARS-CoV-2, legionella und hepatitis among dental staf 2022" }, "short": "Leg-Hep-S22", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-01-01T01:00:00+01:00", "end_planned": "2024-12-31T01:00:00+01:00", "end_effective": "2024-12-31T01:00:00+01:00", "assignment": "2023-01-16T14:19:57+01:00", "program": null, "subprogram": null, "organization": 14109, "category": 10, "type": 10, "partner_function": 4, "manager": 50051, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 457 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "7333-50051-10" ] }, { "id": 6719, "title": { "de": "Risikopersonen für iatrogene Kiefernekrosen und Knochenbrüche bei Osteoporose- und Krebstherapien frühzeitig identifizieren ", "en": "MRONJ and AFF risk identification and prediction in osteoporosis and cancer patients (RIO)" }, "short": "MEFO-RIO", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2021-11-01T01:00:00+01:00", "end_planned": "2024-12-31T01:00:00+01:00", "end_effective": "2026-12-31T01:00:00+01:00", "assignment": "2021-09-30T15:29:09+02:00", "program": null, "subprogram": null, "organization": 14080, "category": 10, "type": 10, "partner_function": 4, "manager": 98005, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 1743 ], "funder_projectcode": "MEFO-65", "ethics_committee": null, "edudract_number": null, "persons": [ "6719-50909-12", "6719-98005-10" ] }, { "id": 7183, "title": { "de": "Optimierung des Katheterwechsels bei der Therapie mit Insulinpumpen mittels Messung des Gewebewiderstands", "en": "Optimising the timing of infusion set replacement in insulin pump therapy using tissue flow resistance monitoring" }, "short": "Opt-INFUSE", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-09-05T02:00:00+02:00", "end_planned": "2023-12-31T01:00:00+01:00", "end_effective": "2024-09-04T02:00:00+02:00", "assignment": "2022-09-26T16:37:02+02:00", "program": null, "subprogram": null, "organization": 14080, "category": 10, "type": 10, "partner_function": 4, "manager": 51831, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 2689 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "7183-51831-10", "7183-50452-12", "7183-103585-12" ] }, { "id": 6939, "title": { "de": "Förderung der Lebensspanne durch Mitohormesis induziert durch mitochondriales Kalzium", "en": "Promotion of lifespan by mitochondrial Ca2+-induced mitohormesis" }, "short": "Ca2+-induced mitohormesis", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-01-01T01:00:00+01:00", "end_planned": "2022-12-31T01:00:00+01:00", "end_effective": "2022-12-31T01:00:00+01:00", "assignment": "2022-03-01T12:10:36+01:00", "program": null, "subprogram": null, "organization": 14013, "category": 10, "type": 10, "partner_function": 4, "manager": 85069, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 1743 ], "funder_projectcode": "MEFO-69", "ethics_committee": null, "edudract_number": null, "persons": [ "6939-85069-10" ] }, { "id": 6931, "title": { "de": "Überwindung von Resistenzen in der Krebstherapie - Identifizierung neuer therapeutischer Angriffspunkte mittels dualen CRISPRko und CRISPRa Screens", "en": "Using dual CRISPRko and CRISPRa screens to identify novel\r\ntargets to overcome cancer drug resistance" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-01-01T01:00:00+01:00", "end_planned": "2024-12-31T01:00:00+01:00", "end_effective": "2024-12-31T01:00:00+01:00", "assignment": "2022-02-17T11:44:31+01:00", "program": null, "subprogram": null, "organization": 14085, "category": 10, "type": 10, "partner_function": 4, "manager": 109002, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 894 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "6931-98327-12", "6931-109501-12", "6931-109002-10" ] }, { "id": 6928, "title": { "de": "Apoptose als therapeutischer Angriffspunkt bei behandlungsresistentem Lungenkrebs", "en": "Targeting the apoptotic pathway to overcome therapy resistance in lung cancer" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-01-01T01:00:00+01:00", "end_planned": "2023-12-31T01:00:00+01:00", "end_effective": "2024-12-31T01:00:00+01:00", "assignment": "2022-02-15T13:14:17+01:00", "program": null, "subprogram": null, "organization": 14085, "category": 10, "type": 10, "partner_function": 4, "manager": 109002, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 1743 ], "funder_projectcode": "MEFO-75", "ethics_committee": null, "edudract_number": null, "persons": [ "6928-109002-10" ] }, { "id": 6944, "title": { "de": "Integriertes Patient*innenmanagement bei Vorhofflimmern: mHealth-Implementierung bis Hybrid-Ablationen", "en": "Integrated patient management for atrial fibrillation: implementation of mHealth, hybrid ablations" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-03-01T01:00:00+01:00", "end_planned": "2023-12-31T01:00:00+01:00", "end_effective": "2024-12-31T01:00:00+01:00", "assignment": "2022-03-03T11:52:28+01:00", "program": null, "subprogram": null, "organization": 14083, "category": 10, "type": 10, "partner_function": 4, "manager": 63032, "contact": null, "status": 2, "research": 5, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 468 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "6944-63032-10" ] }, { "id": 7055, "title": { "de": "Lösung des offenen Rätsels von TRPC3 durch Photopharmakologie", "en": "Resolving the open state enigma of TRPC3 by photopharmacology" }, "short": null, "url": null, "abstract": { "de": "• Wider research context / theoretical framework: TRPC3 is a distinct member of TRPC family. This channel is expressed in excitable and non-excitable cells. By non-selectively conducting cations even at its resting state, TRPC3 promotes cellular processes in both health and disease. However, there are only a few modulators of this channel available. To precisely design new therapeutic ligands, it is of high importance to gain knowledge about TRPC3 protein structure and, consequently, its gating mechanism. Recently, two TRPC3 structures were revealed by cryo electron microscopy (cryo-EM). Nonetheless, neither of them captured open pore architecture. Hence, the open conformations is the critical missing piece of information to solve the TRPC3 gating puzzle. This knowledge is essential for comprehension of the molecular function of TRPC3 and definition of possible ligand binding sites to control this channel is health and, especially, disease.\r\n• Hypotheses / research questions / objectives: Here, we propose to succeed in capturing open pore structures of TRPC3 by stabilizing and synchronizing the channels at a high open probability using photochromic ligands and in addition by preserving their lipid environment during the protein preparation for cryo-EM.\r\n• Approach / methods: We will screen two expression systems for suitability to maintain TRPC3 in open conformation. We will utilize photopharmacological tools for a temporal control over TRPC3 gating during protein extraction and cryo-EM. Structural details obtained from cryo-EM will be followed by structure-guided mutagenesis and evaluated in a multifunctional live cell approach combining Ca2+ imaging and electrophysiology.\r\n• Level of originality / innovation: With our project, we will introduce a novel approach to control protein conformations during cryo-EM by photoswitchable ligands. Our work will unravel TRPC3 open architecture and promote the development of new concepts for therapeutic targeting of these channels.\r\n• Primary researchers involved: The research team will include profound experts in TRPC3 electrophysiology and Ca2+ signaling Dr. Oleksandra Tiapko and Dr. Klaus Groschner (Medical University of Graz, Austria), experts in membrane lipids Dr. Anita Emmerstorfer-Augustin (Graz University of Technology) and in structural biology and electron microscopy Dr. Christine Ziegler (University of Regensburg).", "en": "• Wider research context / theoretical framework: TRPC3 is a distinct member of TRPC family. This channel is expressed in excitable and non-excitable cells. By non-selectively conducting cations even at its resting state, TRPC3 promotes cellular processes in both health and disease. However, there are only a few modulators of this channel available. To precisely design new therapeutic ligands, it is of high importance to gain knowledge about TRPC3 protein structure and, consequently, its gating mechanism. Recently, two TRPC3 structures were revealed by cryo electron microscopy (cryo-EM). Nonetheless, neither of them captured open pore architecture. Hence, the open conformations is the critical missing piece of information to solve the TRPC3 gating puzzle. This knowledge is essential for comprehension of the molecular function of TRPC3 and definition of possible ligand binding sites to control this channel is health and, especially, disease.\r\n• Hypotheses / research questions / objectives: Here, we propose to succeed in capturing open pore structures of TRPC3 by stabilizing and synchronizing the channels at a high open probability using photochromic ligands and in addition by preserving their lipid environment during the protein preparation for cryo-EM.\r\n• Approach / methods: We will screen two expression systems for suitability to maintain TRPC3 in open conformation. We will utilize photopharmacological tools for a temporal control over TRPC3 gating during protein extraction and cryo-EM. Structural details obtained from cryo-EM will be followed by structure-guided mutagenesis and evaluated in a multifunctional live cell approach combining Ca2+ imaging and electrophysiology.\r\n• Level of originality / innovation: With our project, we will introduce a novel approach to control protein conformations during cryo-EM by photoswitchable ligands. Our work will unravel TRPC3 open architecture and promote the development of new concepts for therapeutic targeting of these channels.\r\n• Primary researchers involved: The research team will include profound experts in TRPC3 electrophysiology and Ca2+ signaling Dr. Oleksandra Tiapko and Dr. Klaus Groschner (Medical University of Graz, Austria), experts in membrane lipids Dr. Anita Emmerstorfer-Augustin (Graz University of Technology) and in structural biology and electron microscopy Dr. Christine Ziegler (University of Regensburg)." }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-01-01T01:00:00+01:00", "end_planned": "2025-12-31T01:00:00+01:00", "end_effective": "2026-10-31T01:00:00+01:00", "assignment": "2022-06-13T15:55:42+02:00", "program": 72, "subprogram": null, "organization": 14011, "category": 10, "type": 10, "partner_function": 4, "manager": 90337, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": " P 35291", "ethics_committee": null, "edudract_number": null, "persons": [ "7055-90337-10", "7055-116421-12" ] }, { "id": 7037, "title": { "de": "Innovatives Pilotprojekt: Forschung zur Laserakupunktur und Lasermedizin", "en": "Innovative Pilot Project: Research on Laser Acupuncture and Laser Medicine" }, "short": "Lasermedizin", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-01-01T01:00:00+01:00", "end_planned": "2022-12-31T01:00:00+01:00", "end_effective": "2022-12-31T01:00:00+01:00", "assignment": "2022-05-31T11:14:30+02:00", "program": null, "subprogram": null, "organization": 14044, "category": 10, "type": 10, "partner_function": 4, "manager": null, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 762 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [] }, { "id": 7013, "title": { "de": "LncRNAs in triple negativ breast cancer", "en": "LncRNAs in triple negative breast cancer" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-07-01T02:00:00+02:00", "end_planned": "2025-09-30T02:00:00+02:00", "end_effective": "2023-12-31T01:00:00+01:00", "assignment": "2022-05-11T11:23:48+02:00", "program": 72, "subprogram": null, "organization": 14085, "category": 10, "type": 10, "partner_function": 4, "manager": null, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "P35975", "ethics_committee": null, "edudract_number": null, "persons": [] }, { "id": 7156, "title": { "de": "doc.fund BioMolStruct - Zusatzfinanzierung (2. Förderjahr)", "en": "doc.fund BioMolStruct - Zusatzfinanzierung (2. Förderjahr)" }, "short": "BioMolStruct - ZF", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-01-01T01:00:00+01:00", "end_planned": "2022-12-31T01:00:00+01:00", "end_effective": "2022-12-31T01:00:00+01:00", "assignment": "2022-09-05T15:58:43+02:00", "program": null, "subprogram": null, "organization": 14012, "category": 10, "type": 10, "partner_function": 4, "manager": 91207, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 2471 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "7156-91207-10" ] }, { "id": 6936, "title": { "de": "Epigenetische Regulation der Immunantwort nach COVID-19-Impfung", "en": "Epigenetic regulation of immune responses following COVID-19 vaccination" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-03-01T01:00:00+01:00", "end_planned": "2022-12-31T01:00:00+01:00", "end_effective": "2023-12-31T01:00:00+01:00", "assignment": "2022-02-28T11:42:52+01:00", "program": null, "subprogram": null, "organization": 14014, "category": 10, "type": 10, "partner_function": 4, "manager": 78952, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 2471 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "6936-78952-10" ] }, { "id": 6891, "title": { "de": "Assoziation zwischen nicht-invasiver Diagnostik und Endomyokardbiopsie bei Patient*innen mit suspizierter kardialer Amyloidose - eine multizentrische retrospektive Studie", "en": "Association between non-invasive diagnostics and results of endomyocardial biopsy in patients with suspected cardiac amyloidosis - a multicenter retrospective study" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-01-01T01:00:00+01:00", "end_planned": "2023-12-31T01:00:00+01:00", "end_effective": "2023-12-31T01:00:00+01:00", "assignment": "2022-01-24T11:50:17+01:00", "program": null, "subprogram": null, "organization": 14083, "category": 10, "type": 10, "partner_function": 4, "manager": 81519, "contact": null, "status": 2, "research": 4, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 1743 ], "funder_projectcode": "MEFO-66", "ethics_committee": null, "edudract_number": null, "persons": [ "6891-81519-10" ] }, { "id": 6942, "title": { "de": "CBmed: MODUL - Mikroplastik: Eine Gefahr für die menschliche Gesundheit Projekt 3\r\nInteraktion - Gesundheitseffekte - Prävention", "en": "CBmed: MODUL - Microplastic Particles: A Hazard for Human Health Project 3\r\nINTERACTION – HUMAN HEALTH EFFECTS – TREATMENT" }, "short": "MicroONE", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-01-01T01:00:00+01:00", "end_planned": "2025-12-31T01:00:00+01:00", "end_effective": "2026-12-31T01:00:00+01:00", "assignment": "2022-03-02T13:48:50+01:00", "program": 94, "subprogram": null, "organization": 14081, "category": 10, "type": 10, "partner_function": 4, "manager": 50989, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 416 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "6942-81091-12", "6942-107131-12", "6942-106674-12", "6942-112689-12", "6942-50989-10", "6942-114553-12", "6942-115621-12", "6942-119169-12", "6942-125874-12", "6942-126494-12", "6942-124112-12" ] }, { "id": 6787, "title": { "de": "Apolipoprotein AI (apo-AI) Mimetische \r\nPeptid-Lipid-Assemblies", "en": "Apolipoprotein AI (apo-AI) Mimetic \r\nPeptide Lipid Assemblies" }, "short": "AAMLA", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2022-01-01T01:00:00+01:00", "begin_effective": "2022-01-01T01:00:00+01:00", "end_planned": "2025-12-31T01:00:00+01:00", "end_effective": "2025-12-31T01:00:00+01:00", "assignment": "2021-11-17T15:51:22+01:00", "program": 111, "subprogram": null, "organization": 14022, "category": 10, "type": 10, "partner_function": 2, "manager": 53252, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "I5703", "ethics_committee": null, "edudract_number": null, "persons": [ "6787-53252-10" ] } ] }